Credo Technology Group Holding Ltd
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Here’s Why Credo Technology Group Holding Ltd (CRDO) is on the Detector List of the Fund
Polen Capital, an investment management company, released its second-quarter 2026 investor letter for “Polen 5Perspectives Small Growth Strategy”. A copy of the letter can be downloaded here. Polen 5Perspectives Small Growth Composite Portfolio returned 33.22% gross and 32.83% net of fees, respectively, in the second quarter of 2026, compared to the 25.71% return of the […]
Are Computer and Technology Stocks Lagging Amkor Technology (AMKR) This Year?
Here is how Amkor Technology (AMKR) and Credo Technology Group Holding Ltd. (CRDO) have performed compared to their sector so far this year.
Credo Technology Group (CRDO) Screens as a High-Growth CAN SLIM Leader with Strong Price Momentum
The CAN SLIM system identifies high-growth stocks using seven fundamental and technical criteria. This analysis applies it to Credo Technology Group (CRDO), showing strong earnings, sales growth, and a high RS rating.
Credo's Biggest Shift Is Still Undervalued
Credoâs AI connectivity outlook: $1.3B FY26 revenue, 80%+ FY27 growth, optical products to top $600M, and valuation risks. See here for more on CRDO stock.
Reviewing Recent Picks: Winners, Laggards, And Lessons From SpaceX, Meta, Micron, Bloom, And Credo
Track SpaceX, Meta, Micron, Bloom & Credo with valuation and technical takeaways, AI momentum, and dip-buy targetsâsee what to buy, hold or wait on.
Credo: Buy The Back-Loaded Year, Not The Quarter
Credo Technology's business centers on high-reliability, low-power connectivity solutions for AI data centers, with flagship AECs. Read why CRDO stock is a buy.
Zacks.com featured highlights include Ponce Financial, Credo Technology, Interface, Ciena and Citizens Financial Services
PDLB, CRDO, TILE, CIEN and CZFS stand out on key efficiency metrics, highlighting five stocks with strong profit potential.
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders
On 1 July 2026, Evernorth, The Cigna Group’s health services division, launched Pharmacy Forward, a US$100 million AI-powered program to streamline specialty pharmacy care through Accredo, aiming to accelerate prescription processing, improve adherence, and cut clinician documentation time. The program is intended to generate about US$0.40 billion in value by 2028 while using AI to halve time-to-medication and place 90% of patients within a one-day or same-day shipping radius. We’ll now...
Credo: After Nearly Tripling, The Stock Is Still Cheap
Credo Technology Group maintains a Buy rating after nearly tripling, driven by robust fundamentals and strategic execution. Click for this CRDO stock update.
Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions
As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specific Therapeutic Resource Centers
Congressional Trades in $CRDO
Insider Trades (Form 4)
Cheng Chi Fung
Fleming Daniel W.
Cheng Chi Fung
DANESH FARIBA
Laufman James
Laufman James
Key People
Fleming Daniel W
Chief Financial Officer
Cheng Chi Fung
Chief Technology Officer
DANESH FARIBA
Director
Laufman James
Chief Legal Officer, Secretary
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro